Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
J Hand Surg Am ; 39(2): 385-91, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24411292

ABSTRACT

In isolation, distal ulna fractures are rare. They are often found in conjunction with distal radius fractures, and the complexity of the interaction of the distal ulna with the radioulnar joint and triangular fibrocartilage complex makes understanding and treatment of distal ulna fractures challenging. Fixation of distal ulna fractures can be problematic owing to comminution making reduction challenging. A thin soft tissue can lead to hardware prominence and necessitate implant removal. In this Current Concepts article, we review the anatomy, pathology, and treatment of distal ulna fractures as well as potential complications and salvage procedures.


Subject(s)
Fracture Fixation, Internal/methods , Radius Fractures/surgery , Ulna Fractures/surgery , Wrist Injuries/surgery , Arthroplasty/methods , Bone Plates , Humans , Joint Prosthesis , Postoperative Complications/diagnostic imaging , Postoperative Complications/surgery , Radius Fractures/diagnostic imaging , Radius Fractures/pathology , Reoperation , Salvage Therapy/methods , Tomography, X-Ray Computed , Triangular Fibrocartilage/diagnostic imaging , Triangular Fibrocartilage/injuries , Triangular Fibrocartilage/surgery , Ulna Fractures/diagnostic imaging , Ulna Fractures/pathology , Wrist Injuries/diagnostic imaging , Wrist Injuries/pathology , Wrist Joint/surgery
4.
Middle East J Anaesthesiol ; 18(5): 825-50, 2006 Jun.
Article in English | MEDLINE | ID: mdl-17094522

ABSTRACT

Congestive heart failure (CHF) is increasingly being recognized as a health problem in the United States. It is estimated that the lifetime risk for CHF is 1 in 5. The clinical anesthesiologist can expect to see several cases involving patients suffering from CHF. Because of the danger associated with surgery in a patient with CHF, a thorough knowledge of the disorder and the potential effects on the delivery of anesthetics must be considered. In addition, knowledge of the disease process and its manifestations is required for smooth guidance of the patient through the perioperative period. The understanding of current pharmacotherapies, surgical procedures and their implications related to interactions with anesthetics are all discussed.


Subject(s)
Anesthesia , Heart Failure/physiopathology , Heart Failure/therapy , Anesthesia/adverse effects , Anesthesia/methods , Cardiac Surgical Procedures , Heart Failure/diagnosis , Humans , Perioperative Care
5.
J Med Food ; 9(1): 62-71, 2006.
Article in English | MEDLINE | ID: mdl-16579730

ABSTRACT

This study was designed to test the hypothesis that kava kava induces a depressor response in the pulmonary vascular bed of the cat and to identify the pathways involved in the mediation or modulation of these effects. In separate experiments, the effects of L-N5-(1-iminoethyl)ornithine hydrochloride (L-NIO), a nitric oxide synthase inhibitor, glibenclamide, an ATP-sensitive K+ channel blocker, meclofenamate, a nonselective cyclooxygenase inhibitor, nicardipine, a calcium channel blocker, bicuculline, a gamma-aminobutyric acid (GABA)A receptor antagonist, and saclofen, a GABAB antagonist, were investigated on pulmonary arterial responses to kava kava (kava), pinacidil, an ATP-sensitive K+ channel activator, bradykinin, an inducer of nitric oxide synthase, 3-aminopropyl(methyl)phosphinic acid hydrochloride (SKF-97541), a GABAB receptor agonist, and muscimol, a GABAA receptor agonist. Lobar arterial perfusion pressure and systemic pressure were continuously monitored, electronically averaged, and recorded. Under elevated tone conditions in the isolated left lower lobe of the feline vascular bed, kava induced a dose-dependent vasodepressor response that was not significantly altered after administration of L-NIO, glibenclamide, meclofenamate, or saclofen. Responses to kava were significantly reduced after administration of either nicardipine or bicuculline. When the calcium channel blocker nicardipine was administered in addition to the GABA blocker bicuculline, there was near complete attenuation of the kava-induced vasodepressor responses. The results of this investigation suggest that kava has potent vasodepressor activity in the feline lung bed and that this response is mediated or modulated by both a calcium channel- and GABA receptor-sensitive pathway.


Subject(s)
Kava/chemistry , Lung/blood supply , Plant Extracts/pharmacology , Animals , Baclofen/analogs & derivatives , Baclofen/pharmacology , Bicuculline/pharmacology , Blood Pressure/drug effects , Bradykinin/pharmacology , Calcium Channel Blockers/pharmacology , Calcium Channels/physiology , Cats , Cyclooxygenase Inhibitors , Enzyme Inhibitors/pharmacology , GABA Agonists/pharmacology , GABA Antagonists/pharmacology , Meclofenamic Acid/pharmacology , Muscimol/pharmacology , Nicardipine/pharmacology , Nitric Oxide Synthase/antagonists & inhibitors , Organophosphorus Compounds/pharmacology , Ornithine/analogs & derivatives , Ornithine/pharmacology , Pinacidil/pharmacology , Receptors, GABA/physiology , Vasodilator Agents/pharmacology
6.
Am J Ther ; 12(5): 411-6, 2005.
Article in English | MEDLINE | ID: mdl-16148426

ABSTRACT

The effects of 8-(diethylamino)octyl-3,4,5-trimethoxybenzoate hydrochloride (TMB-8), a protein kinase C (PKC) inhibitor, and thapsigargin, a CaATPase inhibitor, on pressor responses were studied in the pulmonary vascular bed of the intact-chest anesthetized cat. Under conditions of constant lobar blood flow in the cat, injections of the angiotensin peptides (ANG II), norepinephrine (NE), serotonin (5-HT), Bay K 8644, and the thromboxane A2 mimic U46619 into the lobar arterial perfusion circuit caused dose-related increases in lobar arterial pressure and responses were reproducible with respect to time. Intravenous infusion of TMB-8 at 1.0 mug . kg reduced the pressor response to the ANG II and to NE. However, TMB-8 did not alter pressor responses to 5-HT, U46619, or Bay K 8644. In a separate series of experiments, the effects of thapsigargin were investigated and intravenous infusion of the CaATPase inhibitor at 1.0 mug . kg also reduced pressor responses to the ANG II and to NE but did not alter pressor responses to 5-HT, U46619, and Bay K 8644. The data provide support for the hypothesis that vasoconstrictor responses to ANG II and NE in the pulmonary vascular bed are mediated in part by the activation of protein kinase C (PKC) and sarcoplasmic reticulum CaATPase-sensitive mechanisms in the cat. The present data suggest that pulmonary pressor responses to U46619, 5-HT, and Bay K 8644 are not mediated by PKC or CaATPase activation in the pulmonary vascular bed of the cat.


Subject(s)
Calcium-Transporting ATPases/antagonists & inhibitors , Gallic Acid/analogs & derivatives , Lung/blood supply , Protein Kinase C/antagonists & inhibitors , Thapsigargin/pharmacology , Vasoconstriction/drug effects , Animals , Cats , Dose-Response Relationship, Drug , Female , Gallic Acid/pharmacology , Male , Pulmonary Circulation/drug effects , Vasoconstrictor Agents/pharmacology
7.
Middle East J Anaesthesiol ; 18(1): 93-105, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15830765

ABSTRACT

Obesity, the most common nutritional disorder in the United States, has taken on epidemic proportions, spreading rapidly during the 1990s across all states, regions, and demographic groups in the United States, according to the CDC. The presence of coexisting disease, difficulty with airway management and respiratory compromise, as well as alterations in drug metabolism in obese patients, combine to make understanding this particular disorder vital for the clinical anesthesiologist. This review summarizes the clinical presentation, pathophysiology, and treatment of morbid obesity. Preoperative assessment, intraoperative management, and postoperative care, as well as anesthetic management of coexisting disease states of obesity are addressed.


Subject(s)
Obesity, Morbid/physiopathology , Anesthesia , Anesthetics/pharmacology , Functional Residual Capacity , Humans , Intubation, Intratracheal , Obesity, Morbid/therapy , Pneumonia, Aspiration/etiology , Postoperative Care
8.
J Herb Pharmacother ; 4(3): 47-62, 2004.
Article in English | MEDLINE | ID: mdl-15829469

ABSTRACT

OBJECTIVE: To test the hypothesis that St. John's wort induces a depressor response in the feline pulmonary vascular bed and identify the pathways involved in the mediation or modulation of these effects. DESIGN: Prospective vehicle controlled study. SETTING: University research laboratory. SUBJECTS: Intact chest preparation; adult mongrel cats. INTERVENTIONS: In separate experiments, the effects of L-N5-(1-Iminoethyl) ornithine hydrochloride (L-NIO), a nitric oxide synthase inhibitor, glibenclamide, an ATP-sensitive K+ channel blocker, meclofenamate, a non-selective cyclo-oxygenase (COX) inhibitor, nicardipine, a calcium channel blocker, bicuculline, a GABAA receptor antagonist, and saclofen, a GABAB antagonist, were investigated on pulmonary arterial responses of St. John's wort (SJW), pinacidil, an ATP-sensitive K+ channel activator, bradykinin, an inducer of nitric oxide synthase, 3-aminopropyl (methyl) phosphinic acid, hydrochloride (SKF-97541), a GABAB receptor agonist and muscimol, a GABAA receptor agonist. MEASUREMENTS AND MAIN RESULTS: Lobar arterial perfusion pressure and systemic pressure were continuously monitored, electronically averaged and permanently recorded. Under elevated tone conditions in the isolated left lower lobe vascular bed of the cat, SJW induced a dose-dependent vasodepressor response that was not significantly altered after administration of L-NIO, glibenclamide, meclofenamate or saclofen. Responses to SJW were significantly reduced after administration of either nicardipine or bicuculline. When the calcium channel blocker nicardipine was administered in addition to the GABA blocker bicuculline, there was near complete attenuation of the SJW-induced vasodepressor responses. CONCLUSIONS: The results of the present study suggest that SJW has potent vasodepressor activity in the pulmonary vascular bed of the cat and that this response is mediated or modulated by both a calcium channel and GABA receptor sensitive pathway.


Subject(s)
Baclofen/analogs & derivatives , Hypericum , Ornithine/analogs & derivatives , Pulmonary Artery/drug effects , Pulmonary Circulation/drug effects , Vasodilator Agents/pharmacology , Acetylcholine/pharmacology , Animals , Arachidonic Acid/pharmacology , Baclofen/pharmacology , Bicuculline/pharmacology , Bradykinin/pharmacology , Calcium Channel Agonists/pharmacology , Cats , Dose-Response Relationship, Drug , Female , GABA Antagonists/pharmacology , Male , Meclofenamic Acid/pharmacology , Muscimol/pharmacology , Nicardipine/pharmacology , Nitric Oxide Donors/pharmacology , Organophosphorus Compounds/pharmacology , Ornithine/pharmacology , Pinacidil/pharmacology , Plant Extracts/pharmacology , Prospective Studies
9.
J Altern Complement Med ; 9(5): 727-33, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14629850

ABSTRACT

OBJECTIVE: To test the hypothesis that ma huang induces a pressor response in the pulmonary vascular bed of the cat by activating alpha(1)-adrenergic receptors DESIGN: Prospective vehicle-controlled study. SETTING: Research laboratory at Texas Tech University School of Medicine, Lubbock, TX. SUBJECTS: Intact chest preparation; adult mongrel cats. INTERVENTIONS: The effects of phentolamine, a nonselective alpha receptor blocker, and prazosin, an alpha(1) selective antagonist, were investigated on pulmonary arterial responses to ma huang, phenylepherine, norepinephrine, and U-46619, a thromboxane A(2) mimic. MEASUREMENTS AND MAIN RESULTS: Lobar arterial perfusion pressure was continuously monitored, electronically averaged, and recorded with constant flow in the isolated left lower lobe vascular bed of the cat. Phentolamine and prazosin significantly reduced vasoconstrictor pulmonary perfusion pressure increases induced by ma huang. CONCLUSIONS: Ma huang has significant vasopressor activity in the pulmonary vascular bed of the cat mediated predominantly by alpha(1)-adrenergic receptor activation.


Subject(s)
Ephedra sinica , Phytotherapy , Plant Extracts/pharmacology , Pulmonary Circulation/drug effects , Receptors, Adrenergic, alpha-1/drug effects , Vasoconstriction/drug effects , Vasoconstrictor Agents/pharmacology , Adrenergic alpha-Antagonists/pharmacology , Animals , Cats , Disease Models, Animal , Dose-Response Relationship, Drug , Female , Male , Phentolamine/pharmacology , Prazosin/pharmacology , Prospective Studies , Receptors, Adrenergic, alpha-1/metabolism , Time Factors
10.
Can J Anaesth ; 50(7): 663-71, 2003.
Article in English | MEDLINE | ID: mdl-12944440

ABSTRACT

PURPOSE: This review on ultrarapid detoxification examines the pharmacology, techniques, and efficacy of this potentially promising technique and contrasts it with conventional treatment modalities. SOURCE: The information found here is derived from experiences at the Texas Tech University, government reports, and peer reviewed journals. PRINCIPLE FINDINGS: Incidence and prevalence of heroin use is on the rise. Social and treatment costs suggest that this problem is staggering. Approximately 400,000 patients are enrolled in or are actively seeking methadone therapy. While many of these individuals want to undergo detoxification, traditional techniques, including methadone tapering are usually unsuccessful. The withdrawal syndrome is extremely unpleasant, may be fatal, and deters patients from completing the detoxification process. Ultrarapid detoxification entails general anesthesia in conjunction with large boluses of narcotic antagonists. This combination allows the individual to completely withdraw from the opiate without suffering the discomfort of the withdrawal syndrome. Unless performed properly, this procedure can be dangerous due to the sympathetic outflow. However, with proper support, this danger can be mitigated. CONCLUSION: Ultrarapid opiate detoxification, performed under the proper circumstances, is associated with few adverse events and is relatively comfortable for patients who seek treatment for their addition.


Subject(s)
Anesthesia, General , Heroin Dependence/drug therapy , Naltrexone/therapeutic use , Narcotic Antagonists/therapeutic use , Substance Withdrawal Syndrome/prevention & control , Clonidine/therapeutic use , Humans , Intensive Care Units , Naltrexone/adverse effects , Narcotic Antagonists/adverse effects , Pulmonary Edema/etiology , Pulmonary Edema/prevention & control , Sympatholytics/therapeutic use
11.
Br J Plast Surg ; 56(3): 306-8, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12859934

ABSTRACT

The presence of a myelomeningocele at multiple levels along the spinal column is a rare event. There are only a few cases of double myelomeningocele reported in the world's literature. Large myelomeningoceles present surgical closure challenges due to the size and location of these defects. We report the case of a newborn female who had two myelomeningoceles with one at the thoracic level and the other at the lumbar level. Surgical closure must provide durable and stable coverage for the spinal cord. Stable coverage was provided for this patient using bilateral paraspinous myofascial turnover flaps. This unusual case report as well as a review of the literature is presented.


Subject(s)
Meningomyelocele/surgery , Surgical Flaps , Female , Humans , Infant, Newborn , Lumbosacral Region , Meningomyelocele/pathology , Treatment Outcome
12.
J Altern Complement Med ; 9(6): 909-18, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14736362

ABSTRACT

OBJECTIVES: This study was undertaken to investigate pulmonary vascular response to valerian (Valeriana officinalis) in the feline pulmonary vasculature under constant flow conditions. DESIGN: In separate experiments, the effects of NG-L-nitro-L-arginine methyl ester (L-NIO), a nitric oxide synthase inhibitor, glibenclamide, an adenosine triphosphate (ATP)-sensitive potassium (K+) channel blocker, meclofenamate, a nonselective cyclooxygenase (COX) inhibitor, bicuculline, a GABA(A) receptor antagonist, and saclofen, a GABA(B) antagonist, were investigated on pulmonary arterial responses to various agonists in the feline pulmonary vascular bed. These agonists included valerian, muscimol, a GABA(A) agonist, SKF-97541 a GABA(B) agonist, acetylcholine (ACh), and bradykinin, both inducers of nitric oxide synthase, arachidonic acid, a COX substrate, and pinacidil, an ATP-sensitive K+ channel activator, during increased tone conditions induced by the thromboxane A2 mimic, U46619. SETTINGS/LOCATION: Laboratory investigation. SUBJECTS: Mongrel cats of either gender. INTERVENTIONS: Injections of the abovementioned agonists and antagonists were given. OUTCOME MEASURES: Baseline pulmonary tone, responses to the agonists, and responses to the agonists after injections of antagonists were all measured via a pulmonary catheter transducer and recorded. RESULTS: Valerian root extract is a potent smooth muscle dilator in the feline pulmonary vascular bed. The vasodilatory effects of valerian root extract were unchanged after the administration of L-NIO, glibenclamide, and meclofenamate. These effects were ablated, however, by both saclofen and bicuculline. The ability of saclofen and bicuculline to modulate the dilatory effects of valerian root extract was not statistically different. CONCLUSIONS: The vasodilatory effects of valerian root extract are mediated by a nonselective GABA mechanism.


Subject(s)
Phytotherapy , Plant Roots , Pulmonary Artery/drug effects , Pulmonary Circulation/drug effects , Valerian , Acetylcholine/pharmacology , Animals , Arachidonic Acid/pharmacology , Bradykinin/pharmacology , Calcium Channel Agonists/pharmacology , Cats , Disease Models, Animal , Female , Hypertension/chemically induced , Male , Muscimol/pharmacology , Nitric Oxide Donors/pharmacology , Nitroglycerin/pharmacology , Organophosphorus Compounds/pharmacology , Pinacidil/pharmacology , Plant Extracts/pharmacology , Rats , Time Factors , Vascular Resistance/drug effects
13.
Anesth Analg ; 94(6): 1427-33, table of contents, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12032000

ABSTRACT

UNLABELLED: Calcium-sensitizing drugs, such as levosimendan, are a novel class of drug therapy for heart failure. We investigated the hypothesis that levosimendan is a pulmonary vasodepressor mediated through inhibition of phosphodiesterase, adenosine triphosphate (ATP)-dependent potassium channels, or both. We investigated responses to the calcium sensitizer levosimendan in the pulmonary vascular bed of the cat under conditions of controlled pulmonary blood flow and constant left atrial pressure when lobar arterial pressure was increased to a high steady level with the thromboxane A(2) analog U-46619. Under increased-tone conditions, levosimendan caused dose-related decreases in lobar arterial pressure without altering systemic arterial and left atrial pressure. Responses to levosimendan were significantly attenuated, although not completely, after the administration of U-37883A, a vascular selective nonsulfonylurea ATP-sensitive K(+)-channel-blocking drug. Responses to levosimendan were not significantly different after the administration of the nitric oxide synthase inhibitor L-N(5)-(1-iminoethyl)-ornithine or the cyclooxygenase inhibitor sodium meclofenamate or when lung ventilation was interrupted. These data show that levosimendan has significant vasodilator activity in the pulmonary vascular bed of the cat. They also suggest that pulmonary vasodilator responses to levosimendan are partially dependent on activation of ATP-sensitive K(+) channels and independent of the synthesis of nitric oxide, activation of cyclooxygenase enzyme, or changes in bronchomotor tone in the pulmonary vascular bed of the cat. IMPLICATIONS: Calcium-sensitizing drugs, such as levosimendan, are a novel class of drug therapy for heart-failure treatment. The lung circulation affects both right- and left-sided heart failure. Levosimendan decreased lobar arterial pressure via a partial K(+)(ATP) (potassium channel sensitive to intracellular adenosine triphosphate levels)-dependent mechanism. These data suggest that, in addition to calcium-sensitizing activity, levosimendan decreases pulmonary resistance, which may also aid in the treatment of heart failure.


Subject(s)
Cardiotonic Agents/blood , Hydrazones/blood , Potassium Channels , Pulmonary Circulation/drug effects , Pyridazines/blood , 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid/pharmacology , 3',5'-Cyclic-AMP Phosphodiesterases/antagonists & inhibitors , ATP-Binding Cassette Transporters , Animals , Blood Gas Analysis , Blood Pressure/drug effects , Cats , Coronary Circulation/drug effects , Cyclic Nucleotide Phosphodiesterases, Type 3 , Depression, Chemical , Dose-Response Relationship, Drug , KATP Channels , Nitric Oxide/physiology , Phosphodiesterase Inhibitors/pharmacology , Potassium Channel Blockers , Potassium Channels, Inwardly Rectifying , Prostaglandin-Endoperoxide Synthases/metabolism , Simendan
SELECTION OF CITATIONS
SEARCH DETAIL
...